Vanda Pharmaceuticals (VNDA) EV to EBITDA (2011 - 2023)
Vanda Pharmaceuticals' (VNDA) EV to EBITDA stood at -102.74 in Q3 2023, compared with 9.30 a year earlier.
Powered by 
Analysis
Vanda Pharmaceuticals (VNDA) EV to EBITDA (2011 - 2023) Analysis & Trends
On a TTM basis, Vanda Pharmaceuticals' EV to EBITDA came in at -723.30 as of Sep 30, 2023; for FY2022, it was -5.21.
- Across earlier years, EV to EBITDA came in at 9.86 in FY2021 (-15.9%), 11.73 in FY2020 (-46.8%), 22.03 in FY2019 (-51.2%) and 45.11 in FY2018.
- The Q3 2023 figure is the lowest quarterly EV to EBITDA in data going back to Q2 2011.
- Peak year-over-year performance for EV to EBITDA in the last five years was growth of 73.0% in Q2 2021, against a decline of 94.5% in Q2 2019 at the low end.
- Per Business Quant, the preceding three quarters came in at -8.94 (Q2 2023), -5.94 (Q1 2023) and -5.18 (Q4 2022).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Vanda Pharmaceuticals | 296.83 Mn | -633.11 Mn | 46.97 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2023 | -102.74 |
| Jun 30, 2023 | -8.94 |
| Mar 31, 2023 | -5.94 |
| Dec 31, 2022 | -5.18 |
| Sep 30, 2022 | 9.30 |
| Jun 30, 2022 | 9.67 |
| Mar 31, 2022 | 7.52 |
| Dec 31, 2021 | 9.84 |
| Sep 30, 2021 | 11.69 |
| Jun 30, 2021 | 18.24 |
| Mar 31, 2021 | 11.22 |
| Dec 31, 2020 | 11.69 |
| Sep 30, 2020 | 7.48 |
| Jun 30, 2020 | 10.54 |
| Mar 31, 2020 | 8.95 |
| Dec 31, 2019 | 21.98 |
| Sep 30, 2019 | 15.33 |
| Jun 30, 2019 | 17.98 |
| Mar 31, 2019 | 34.98 |
| Dec 31, 2018 | 45.01 |
API Access
Vanda Pharmaceuticals EV to EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=VNDA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-ebitda", "ticker": "VNDA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=VNDA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();